A citation-based method for searching scientific literature

Valentino Bezzerri, Martina Api, Marisole Allegri, Benedetta Fabrizzi, Seth J Corey, Marco Cipolli. Int J Mol Sci 2020
Times Cited: 4







List of co-cited articles
74 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice.
Masayuki Arakawa, Masataka Shiozuka, Yuki Nakayama, Takahiko Hara, Masa Hamada, Shin'ichi Kondo, Daishiro Ikeda, Yoshikazu Takahashi, Ryuichi Sawa, Yoshiaki Nonomura,[...]. J Biochem 2003
78
75

Amlexanox provides a potential therapy for nonsense mutations in the lysosomal storage disorder Aspartylglucosaminuria.
Antje Banning, Manuel Schiff, Ritva Tikkanen. Biochim Biophys Acta Mol Basis Dis 2018
17
75

PTC124 targets genetic disorders caused by nonsense mutations.
Ellen M Welch, Elisabeth R Barton, Jin Zhuo, Yuki Tomizawa, Westley J Friesen, Panayiota Trifillis, Sergey Paushkin, Meenal Patel, Christopher R Trotta, Seongwoo Hwang,[...]. Nature 2007
726
75

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.
Eitan Kerem, Michael W Konstan, Kris De Boeck, Frank J Accurso, Isabelle Sermet-Gaudelus, Michael Wilschanski, J Stuart Elborn, Paola Melotti, Inez Bronsveld, Isabelle Fajac,[...]. Lancet Respir Med 2014
218
75


The nucleoside analog clitocine is a potent and efficacious readthrough agent.
Westley J Friesen, Christopher R Trotta, Yuki Tomizawa, Jin Zhuo, Briana Johnson, Jairo Sierra, Bijoyita Roy, Marla Weetall, Jean Hedrick, Josephine Sheedy,[...]. RNA 2017
15
75

Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression.
Bijoyita Roy, Westley J Friesen, Yuki Tomizawa, John D Leszyk, Jin Zhuo, Briana Johnson, Jumana Dakka, Christopher R Trotta, Xiaojiao Xue, Venkateshwar Mutyam,[...]. Proc Natl Acad Sci U S A 2016
89
75

Deciphering the reading of the genetic code by near-cognate tRNA.
Sandra Blanchet, David Cornu, Isabelle Hatin, Henri Grosjean, Pierre Bertin, Olivier Namy. Proc Natl Acad Sci U S A 2018
21
75


Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ELX-02, a Potential Treatment for Genetic Disorders Caused by Nonsense Mutations, in Healthy Volunteers.
Andi Leubitz, Anat Frydman-Marom, Neal Sharpe, John van Duzer, Kathleen C M Campbell, Frédéric Vanhoutte. Clin Pharmacol Drug Dev 2019
25
75

Deciphering the Nonsense Readthrough Mechanism of Action of Ataluren: An in Silico Compared Study.
Marco Tutone, Ivana Pibiri, Laura Lentini, Andrea Pace, Anna Maria Almerico. ACS Med Chem Lett 2019
12
75

Nonsense suppression by near-cognate tRNAs employs alternative base pairing at codon positions 1 and 3.
Bijoyita Roy, John D Leszyk, David A Mangus, Allan Jacobson. Proc Natl Acad Sci U S A 2015
63
75

Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial.
Eitan Kerem, Samit Hirawat, Shoshana Armoni, Yasmin Yaakov, David Shoseyov, Michael Cohen, Malka Nissim-Rafinia, Hannah Blau, Joseph Rivlin, Micha Aviram,[...]. Lancet 2008
288
75

Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin.
Liat Linde, Stephanie Boelz, Malka Nissim-Rafinia, Yifat S Oren, Michael Wilschanski, Yasmin Yaacov, Dov Virgilis, Gabriele Neu-Yilik, Andreas E Kulozik, Eitan Kerem,[...]. J Clin Invest 2007
193
75

Suppression of Nonsense Mutations by New Emerging Technologies.
Pedro Morais, Hironori Adachi, Yi-Tao Yu. Int J Mol Sci 2020
14
75

Rescuing the CFTR protein function: Introducing 1,3,4-oxadiazoles as translational readthrough inducing drugs.
Ivana Pibiri, Laura Lentini, Raffaella Melfi, Marco Tutone, Sara Baldassano, Paola Ricco Galluzzo, Aldo Di Leonardo, Andrea Pace. Eur J Med Chem 2018
13
50

Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124.
Douglas S Auld, Scott Lovell, Natasha Thorne, Wendy A Lea, David J Maloney, Min Shen, Ganesha Rai, Kevin P Battaile, Craig J Thomas, Anton Simeonov,[...]. Proc Natl Acad Sci U S A 2010
125
50

Inhibition of nonsense-mediated mRNA decay rescues the phenotype in Ullrich's disease.
Fusako Usuki, Akio Yamashita, Itsuro Higuchi, Tetsuo Ohnishi, Tadafumi Shiraishi, Mitsuhiro Osame, Shigeo Ohno. Ann Neurol 2004
66
50

Specific inhibition of nonsense-mediated mRNA decay components, SMG-1 or Upf1, rescues the phenotype of Ullrich disease fibroblasts.
Fusako Usuki, Akio Yamashita, Isao Kashima, Itsuro Higuchi, Mitsuhiro Osame, Shigeo Ohno. Mol Ther 2006
66
50

Ataluren as an agent for therapeutic nonsense suppression.
Stuart W Peltz, Manal Morsy, Ellen M Welch, Allan Jacobson. Annu Rev Med 2013
102
50

Ataluren for the Treatment of Usher Syndrome 2A Caused by Nonsense Mutations.
Ananya Samanta, Katarina Stingl, Susanne Kohl, Jessica Ries, Joshua Linnert, Kerstin Nagel-Wolfrum. Int J Mol Sci 2019
13
50

Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons.
Maciej Dabrowski, Zuzanna Bukowy-Bieryllo, Ewa Zietkiewicz. Mol Med 2018
58
50

Translational readthrough potential of natural termination codons in eucaryotes--The impact of RNA sequence.
Maciej Dabrowski, Zuzanna Bukowy-Bieryllo, Ewa Zietkiewicz. RNA Biol 2015
76
50

Attenuation of nonsense-mediated mRNA decay enhances in vivo nonsense suppression.
Kim M Keeling, Dan Wang, Yanying Dai, Srinivasan Murugesan, Balachandra Chenna, Jeremy Clark, Valery Belakhov, Jeyakumar Kandasamy, Sadanandan E Velu, Timor Baasov,[...]. PLoS One 2013
68
50


Caffeine boosts Ataluren's readthrough activity.
Laura Lentini, Raffaella Melfi, Patrizia Cancemi, Ivana Pibiri, Aldo Di Leonardo. Heliyon 2019
8
50

Engineered transfer RNAs for suppression of premature termination codons.
John D Lueck, Jae Seok Yoon, Alfredo Perales-Puchalt, Adam L Mackey, Daniel T Infield, Mark A Behlke, Marshall R Pope, David B Weiner, William R Skach, Paul B McCray,[...]. Nat Commun 2019
24
50

Evidence of efficient stop codon readthrough in four mammalian genes.
Gary Loughran, Ming-Yuan Chou, Ivaylo P Ivanov, Irwin Jungreis, Manolis Kellis, Anmol M Kiran, Pavel V Baranov, John F Atkins. Nucleic Acids Res 2014
109
50

Stimulation of stop codon readthrough: frequent presence of an extended 3' RNA structural element.
Andrew E Firth, Norma M Wills, Raymond F Gesteland, John F Atkins. Nucleic Acids Res 2011
93
50


Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations.
Venkateshwar Mutyam, Ming Du, Xiaojiao Xue, Kim M Keeling, E Lucile White, J Robert Bostwick, Lynn Rasmussen, Bo Liu, Marina Mazur, Jeong S Hong,[...]. Am J Respir Crit Care Med 2016
52
50

A meta-analysis of nonsense mutations causing human genetic disease.
Matthew Mort, Dobril Ivanov, David N Cooper, Nadia A Chuzhanova. Hum Mutat 2008
197
50

Novel small molecules potentiate premature termination codon readthrough by aminoglycosides.
Alireza Baradaran-Heravi, Aruna D Balgi, Carla Zimmerman, Kunho Choi, Fahimeh S Shidmoossavee, Jason S Tan, Célia Bergeaud, Alexandra Krause, Stéphane Flibotte, Yoko Shimizu,[...]. Nucleic Acids Res 2016
40
50

Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor.
Xiaojiao Xue, Venkateshwar Mutyam, Liping Tang, Silpak Biswas, Ming Du, Laura A Jackson, Yanying Dai, Valery Belakhov, Moran Shalev, Fuquan Chen,[...]. Am J Respir Cell Mol Biol 2014
97
50

The novel aminoglycoside, ELX-02, permits CTNSW138X translational read-through and restores lysosomal cystine efflux in cystinosis.
Emma J Brasell, Lee Lee Chu, Murielle M Akpa, Idit Eshkar-Oren, Iris Alroy, Rachel Corsini, Brian M Gilfix, Yojiro Yamanaka, Pedro Huertas, Paul Goodyer. PLoS One 2019
12
50


Translation termination depends on the sequential ribosomal entry of eRF1 and eRF3.
Christian Beißel, Bettina Neumann, Simon Uhse, Irene Hampe, Prajwal Karki, Heike Krebber. Nucleic Acids Res 2019
12
50

Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene.
B S Kerem, J Zielenski, D Markiewicz, D Bozon, E Gazit, J Yahav, D Kennedy, J R Riordan, F S Collins, J M Rommens. Proc Natl Acad Sci U S A 1990
449
50


The DEAD-box RNA helicase Dbp5 functions in translation termination.
Thomas Gross, Anja Siepmann, Dorotheé Sturm, Merle Windgassen, John J Scarcelli, Matthias Seedorf, Charles N Cole, Heike Krebber. Science 2007
101
50

Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations.
Igor Nudelman, Annie Rebibo-Sabbah, Dalia Shallom-Shezifi, Mariana Hainrichson, Ido Stahl, Tamar Ben-Yosef, Timor Baasov. Bioorg Med Chem Lett 2006
50
50

Pharmaceutical therapies to recode nonsense mutations in inherited diseases.
Hui-Ling Rose Lee, Joseph P Dougherty. Pharmacol Ther 2012
88
50

The crystal structure of human eukaryotic release factor eRF1--mechanism of stop codon recognition and peptidyl-tRNA hydrolysis.
H Song, P Mugnier, A K Das, H M Webb, D R Evans, M F Tuite, B A Hemmings, D Barford. Cell 2000
345
50

L-MPZ, a novel isoform of myelin P0, is produced by stop codon readthrough.
Yoshihide Yamaguchi, Akiko Hayashi, Celia W Campagnoni, Akio Kimura, Takashi Inuzuka, Hiroko Baba. J Biol Chem 2012
38
50

Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy.
L V Zingman, S Park, T M Olson, A E Alekseev, A Terzic. Clin Pharmacol Ther 2007
89
50

Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa.
Velina S Atanasova, Qiujie Jiang, Marco Prisco, Christina Gruber, Josefina Piñón Hofbauer, Mei Chen, Cristina Has, Leena Bruckner-Tuderman, John A McGrath, Jouni Uitto,[...]. J Invest Dermatol 2017
40
50

New Negamycin-Based Potent Readthrough Derivative Effective against TGA-Type Nonsense Mutations.
Keisuke Hamada, Noriko Omura, Akihiro Taguchi, Alireza Baradaran-Heravi, Masaya Kotake, Misaki Arai, Kentaro Takayama, Atsuhiko Taniguchi, Michel Roberge, Yoshio Hayashi. ACS Med Chem Lett 2019
7
50

Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy.
Richard S Finkel, Kevin M Flanigan, Brenda Wong, Carsten Bönnemann, Jacinda Sampson, H Lee Sweeney, Allen Reha, Valerie J Northcutt, Gary Elfring, Jay Barth,[...]. PLoS One 2013
145
50

2-Aminothiazole-4-carboxamides Enhance Readthrough of Premature Termination Codons by Aminoglycosides.
Safwat M Rabea, Alireza Baradaran-Heravi, Aruna D Balgi, Alexandra Krause, Sara Hosseini Farahabadi, Michel Roberge, David S Grierson. ACS Med Chem Lett 2019
7
50

Aminoglycosides: nephrotoxicity.
M P Mingeot-Leclercq, P M Tulkens. Antimicrob Agents Chemother 1999
489
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.